SILO | tickerfilter.com

Fundamental analysis

17%

Profitability 0%

Dept financing 12%

Liquidity 0%

Performance 40%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-8.35%

1 Month

-20.18%

3 Months

-29.30%

6 Months

-29.30%

1 Year

-29.30%

2 Year

-29.30%

Key data

Stock price

$0.99

P/E Ratio

0.00

DAY RANGE

$0.99 - $1.05

EPS

-$0.38

52 WEEK RANGE

$0.99 - $1.49

52 WEEK CHANGE

-$29.30

MARKET CAP

3.276 M

YIELD

N/A

SHARES OUTSTANDING

0.000

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

04-15-2025

BETA

0.00

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

$45,602

AVERAGE 30 VOLUME

$130,968

Company detail

CEO: Eric Weisblum
Region: US
Website: silopharma.com
Employees: 2
IPO year: 2014

Issue type:
Market: XNAS
Industry: Apparel/Apparel And Other Finished Products
Sector: Manufacturing

Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University of Maryland, The Regents of The University of California, and Columbia University.

SILO - Silo Pharma, Inc.